These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2013 related items for PubMed ID: 18536138

  • 1. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

  • 2. Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.
    Prescrire Int; 2005 Feb; 14(75):5-9. PubMed ID: 15747448
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J, Takeda T, Sato Y.
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [Abstract] [Full Text] [Related]

  • 4. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [Abstract] [Full Text] [Related]

  • 5. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.
    Int J Clin Pharmacol Res; 2004 Dec; 24(1):1-10. PubMed ID: 15575171
    [Abstract] [Full Text] [Related]

  • 6. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010 Dec; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [Abstract] [Full Text] [Related]

  • 7. [Postmenopausal osteoporosis].
    László A.
    Orv Hetil; 2004 Jan 04; 145(1):3-13. PubMed ID: 15222134
    [Abstract] [Full Text] [Related]

  • 8. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP.
    Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222
    [Abstract] [Full Text] [Related]

  • 9. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES, Baim S, Nattiv A.
    Postgrad Med; 2010 Jan 13; 122(1):82-90. PubMed ID: 20107292
    [Abstract] [Full Text] [Related]

  • 10. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD.
    CMAJ; 2007 Sep 11; 177(6):575-80. PubMed ID: 17846439
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology, etiology, and diagnosis of osteoporosis.
    Lane NE.
    Am J Obstet Gynecol; 2006 Feb 11; 194(2 Suppl):S3-11. PubMed ID: 16448873
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G, Ziegler R.
    Ther Umsch; 1994 Nov 11; 51(11):737-47. PubMed ID: 7839332
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML.
    Arch Intern Med; 2004 May 24; 164(10):1108-12. PubMed ID: 15159268
    [Abstract] [Full Text] [Related]

  • 14. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G, EPIDOS Study Group.
    Osteoporos Int; 2002 Jul 24; 13(7):593-9. PubMed ID: 12111021
    [Abstract] [Full Text] [Related]

  • 15. New possibilities for diagnosis and treatment of osteoporosis.
    Miller PD.
    Int J Fertil Womens Med; 2001 Jul 24; 46(4):215-21. PubMed ID: 11563832
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL, Shen W, Minshall ME, Xie S, Moses KH.
    J Rheumatol; 2007 Jan 24; 34(1):140-4. PubMed ID: 17216681
    [Abstract] [Full Text] [Related]

  • 17. Strategies for treatment to prevent fragility fractures in postmenopausal women.
    Geusens P.
    Best Pract Res Clin Rheumatol; 2009 Dec 24; 23(6):727-40. PubMed ID: 19945685
    [Abstract] [Full Text] [Related]

  • 18. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM, Hillner BE.
    J Rheumatol; 2003 Jan 24; 30(1):132-8. PubMed ID: 12508402
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic prevention of osteoporotic fractures.
    Zizic TM.
    Am Fam Physician; 2004 Oct 01; 70(7):1293-300. PubMed ID: 15508540
    [Abstract] [Full Text] [Related]

  • 20. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis.
    Marcus R, Wang O, Satterwhite J, Mitlak B.
    J Bone Miner Res; 2003 Jan 01; 18(1):18-23. PubMed ID: 12510801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 101.